Statistical models predict benefit of non-intensive AML therapy

An international team has developed statistical models to predict the risk of early death in patients being treated with non-intensive therapies for acute myeloid leukemia (AML). Results of analyses using the models will be given in an oral presentation at the 2021 American Society of Hematology (ASH) Annual Meeting on December 11.

source https://medicalxpress.com/news/2021-12-statistical-benefit-non-intensive-aml-therapy.html